Waukee, IANow Enrolling

Mantle Cell Lymphoma Clinical Trial in Waukee, IA

Access cutting-edge mantle cell lymphoma treatment through this clinical trial at a research site in Waukee. Study-provided care at no cost to qualified participants.

Expert Care

Access mantle cell lymphoma specialists in Waukee at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mantle cell lymphoma treatment provided free

About This Mantle Cell Lymphoma Study in Waukee

The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus zanubrutinib versus zanubrutinib plus placebo.

Sponsor: BeiGene

Apply for This Waukee Location

Check if you qualify for this mantle cell lymphoma clinical trial in Waukee, IA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Mantle Cell Lymphoma Treatment Options in Waukee, IA

If you're searching for mantle cell lymphoma treatment options in Waukee, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Waukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mantle cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Mantle Cell Lymphoma?

  • Access to new treatments before they're widely available
  • Receive care from leading mantle cell lymphoma specialists in Waukee
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel